408 related articles for article (PubMed ID: 36671552)
1. The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers.
Di Pietro P; Izzo C; Abate AC; Iesu P; Rusciano MR; Venturini E; Visco V; Sommella E; Ciccarelli M; Carrizzo A; Vecchione C
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671552
[TBL] [Abstract][Full Text] [Related]
2. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
[TBL] [Abstract][Full Text] [Related]
3. Rewiring Endothelial Sphingolipid Metabolism to Favor S1P Over Ceramide Protects From Coronary Atherosclerosis.
Manzo OL; Nour J; Sasset L; Marino A; Rubinelli L; Palikhe S; Smimmo M; Hu Y; Bucci MR; Borczuk A; Elemento O; Freed JK; Norata GD; Di Lorenzo A
Circ Res; 2024 Apr; 134(8):990-1005. PubMed ID: 38456287
[TBL] [Abstract][Full Text] [Related]
4. The antithetic role of ceramide and sphingosine-1-phosphate in cardiac dysfunction.
Cirillo F; Piccoli M; Ghiroldi A; Monasky MM; Rota P; La Rocca P; Tarantino A; D'Imperio S; Signorelli P; Pappone C; Anastasia L
J Cell Physiol; 2021 Jul; 236(7):4857-4873. PubMed ID: 33432663
[TBL] [Abstract][Full Text] [Related]
5. Effects of sphingolipid metabolism disorders on endothelial cells.
Lai Y; Tian Y; You X; Du J; Huang J
Lipids Health Dis; 2022 Oct; 21(1):101. PubMed ID: 36229882
[TBL] [Abstract][Full Text] [Related]
6. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders.
Czubowicz K; Jęśko H; Wencel P; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Aug; 56(8):5436-5455. PubMed ID: 30612333
[TBL] [Abstract][Full Text] [Related]
7. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space.
Tani M; Ito M; Igarashi Y
Cell Signal; 2007 Feb; 19(2):229-37. PubMed ID: 16963225
[TBL] [Abstract][Full Text] [Related]
8. Role of Ceramidases in Sphingolipid Metabolism and Human Diseases.
Parveen F; Bender D; Law SH; Mishra VK; Chen CC; Ke LY
Cells; 2019 Dec; 8(12):. PubMed ID: 31817238
[TBL] [Abstract][Full Text] [Related]
9. Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.
Blaho VA
Adv Exp Med Biol; 2020; 1274():101-135. PubMed ID: 32894509
[TBL] [Abstract][Full Text] [Related]
10. Probing compartment-specific sphingolipids with targeted bacterial sphingomyelinases and ceramidases.
Sakamoto W; Canals D; Salamone S; Allopenna J; Clarke CJ; Snider J; Obeid LM; Hannun YA
J Lipid Res; 2019 Nov; 60(11):1841-1850. PubMed ID: 31243119
[TBL] [Abstract][Full Text] [Related]
11. Control of metabolism and signaling of simple bioactive sphingolipids: Implications in disease.
Gangoiti P; Camacho L; Arana L; Ouro A; Granado MH; Brizuela L; Casas J; Fabriás G; Abad JL; Delgado A; Gómez-Muñoz A
Prog Lipid Res; 2010 Oct; 49(4):316-34. PubMed ID: 20193711
[TBL] [Abstract][Full Text] [Related]
12. The effect of high-fat diet on the sphingolipid pathway of signal transduction in regenerating rat liver.
Zabielski P; Baranowski M; Błachnio-Zabielska A; Zendzian-Piotrowska M; Górski J
Prostaglandins Other Lipid Mediat; 2010 Nov; 93(3-4):75-83. PubMed ID: 20599517
[TBL] [Abstract][Full Text] [Related]
13. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate.
Kihara A; Mitsutake S; Mizutani Y; Igarashi Y
Prog Lipid Res; 2007 Mar; 46(2):126-44. PubMed ID: 17449104
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of ceramide and sphingosine 1-phosphate on ERM phosphorylation: probing sphingolipid signaling at the outer plasma membrane.
Canals D; Jenkins RW; Roddy P; Hernández-Corbacho MJ; Obeid LM; Hannun YA
J Biol Chem; 2010 Oct; 285(42):32476-85. PubMed ID: 20679347
[TBL] [Abstract][Full Text] [Related]
15. [The role of sphingolipids in selected cardiovascular diseases].
Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Chabowska A; Łukaszuk B; Żendzian-Piotrowska M
Postepy Hig Med Dosw (Online); 2013 Sep; 67():1018-26. PubMed ID: 24088546
[TBL] [Abstract][Full Text] [Related]
16. Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer's Disease and Other Neurodegenerative Diseases.
Custodia A; Romaus-Sanjurjo D; Aramburu-Núñez M; Álvarez-Rafael D; Vázquez-Vázquez L; Camino-Castiñeiras J; Leira Y; Pías-Peleteiro JM; Aldrey JM; Sobrino T; Ouro A
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897658
[TBL] [Abstract][Full Text] [Related]
17. Sphingolipids in neurodegeneration (with focus on ceramide and S1P).
Wang G; Bieberich E
Adv Biol Regul; 2018 Dec; 70():51-64. PubMed ID: 30287225
[TBL] [Abstract][Full Text] [Related]
18. Ceramide Signaling and Metabolism in Pathophysiological States of the Lung.
Petrache I; Berdyshev EV
Annu Rev Physiol; 2016; 78():463-80. PubMed ID: 26667073
[TBL] [Abstract][Full Text] [Related]
19. [Recent advances in study of sphingolipids on liver diseases].
Wang SY; Zhang JL; Zhang D; Bao XQ; Sun H
Yao Xue Xue Bao; 2015 Dec; 50(12):1551-8. PubMed ID: 27169276
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy selection pressure alters sphingolipid composition and mitochondrial bioenergetics in resistant HL-60 cells.
Kao LP; Morad SAF; Davis TS; MacDougall MR; Kassai M; Abdelmageed N; Fox TE; Kester M; Loughran TP; Abad JL; Fabrias G; Tan SF; Feith DJ; Claxton DF; Spiegel S; Fisher-Wellman KH; Cabot MC
J Lipid Res; 2019 Sep; 60(9):1590-1602. PubMed ID: 31363040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
